Taken together, our study firstly proves that circRIP2 enables to regulate Tgf-β pathway and promotes bladder cancer progression; besides, the research also suggests a new therapeutic target and biomarker for bladder cancer. This evidence concerns the gene TGFB1 and urinary bladder carcinoma.